Loading
Latest filing published 11 May 2026 for 에이프로젠. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 김정출 across 2 companies, led by 에이프로젠 and 에이프로젠바이오로직스. Between 8 May 2026 and 11 May 2026, the trades on record add up to 2 filings.
Both buying and selling appear: 1 purchase, against 1 sale. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 11 May 2026 came the latest disclosure, an open-market purchase in 에이프로젠. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.